Summary of Key Points Core Viewpoint The company has approved guarantees for its wholly-owned subsidiaries, Guizhou Daqin Tumor Hospital Co., Ltd. and Guizhou Chitianhua Tongzi Chemical Co., Ltd., to support their financing needs, with a total guarantee limit set for the year 2025. Group 1: Guarantee Overview - The company has approved a total guarantee amount of up to 1.8 billion yuan for its subsidiaries in 2025, including a maximum of 600 million yuan for third-party guarantees [1][2] - As of June 30, 2025, the total external guarantees provided by the company and its subsidiaries amount to 1.1702844 billion yuan, which is 45.99% of the company's latest audited net assets [1][15] - There are no overdue guarantees as of the announcement date [1][15] Group 2: Details of the Guaranteed Subsidiaries - Guizhou Daqin Tumor Hospital Co., Ltd. has total assets of 1.16916789 billion yuan and liabilities of 807.8614 million yuan as of March 31, 2025, with a net loss of 29.8208 million yuan in Q1 2025 [4][3] - Guizhou Chitianhua Tongzi Chemical Co., Ltd. has total assets of 2.7281658 billion yuan and liabilities of 1.1726276 billion yuan as of March 31, 2025, with a net profit of 1.37773 million yuan in Q1 2025 [6][5] Group 3: Guarantee Agreements - The company has entered into a guarantee agreement with Guizhou Bank for a loan of 30 million yuan to Guizhou Daqin Tumor Hospital, with a guarantee period of three years from the loan's maturity [7][6] - For Guizhou Chitianhua Tongzi Chemical, the company has provided guarantees for multiple loans, including a maximum of 145 million yuan for various financing needs, with similar guarantee terms [10][9] - The guarantees cover all principal, interest, penalties, and related costs incurred in the event of default [11][10]
证券代码：600227 证券简称：赤天化 编号：2025-048